RaySearch Laboratories AB (publ) announced today that The US Oncology Network, one of America’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care, has selected RayStation to be offered throughout The US Oncology Network as one of the available radiation therapy treatment planning systems.
The US Oncology Network is comprised of more than 350 sites of care and approximately 1,000 independent, community-based physicians who treat more than 800,000 patients annually. 90 sites are radiation oncology facilities and about 140 physicians specialize in radiation oncology. Many of the centers offer a complete array of treatments to give patients a continuity of care that is state-of-the-art, yet cost effective. Physicians throughout The Network collaborate and take part in programs to assure that they are optimizing treatment possibilities.
“We initiated an effort almost two years ago to assess treatment planning solutions being developed in the marketplace,” said Jeff Limmer, director of medical physics and quality, The US Oncology Network. “In this era of quickly emerging technologies, it is extremely important to continually assess projected capability, and then to plan, in both clinically and fiscally responsible ways, for the incorporation of tools and resources which provide high quality care for patients. RayStation will be key in helping us achieve our goals.”
Marc Mlyn, president and CEO of RaySearch’s U.S. sales organization, RaySearch Americas, Inc., said, “There was a great deal of time and effort spent analyzing RayStation as a product and RaySearch as a company to be sure that practices in The US Oncology Network could achieve a high level of efficiency through centralized planning and remote access, and just as importantly that we had the ability to provide them with advanced technologies for the future. This is about a collaboration to put great technology into the hands of the practitioners in this very large network. We look forward to a long and successful future with them.”
Johan Löf, president and CEO of RaySearch, added, “It is satisfying to see that we are making our way into not only stand-alone centers and University Hospitals, but also into strategic and coordinated networks of community-based practices. This is a strong indicator that we are providing the products and services necessary to solidify our position as one of the leading suppliers of treatment planning systems in the U.S. market.”
Radiation therapy departments in The US Oncology Network now have the opportunity to select RayStation® as their treatment planning system. The first purchase made was at the Texas Center for Proton Therapy in June of 2015, previously announced.
For more information: www.raysearchlabs.com